Carbon ion radiotherapy in a hypofractionation regimen for stage I non-small-cell lung cancer
Introduction: In 1994, we started carbon-ion radiotherapy (CIRT) for peripheral stage I non-small-cell lung cancer (NSCLC). First, two phase I/II clinical trials demonstrated the optimal doses of 90.0 GyE in 18 fractions over 6 weeks (Protocol 9303) and 72.0 GyE in 9 fractions over 3 weeks (Protocol...
Main Authors: | , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Oxford University Press
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941516/ |